Cargando…
Ability to Suppress TGF-β-Activated Myofibroblast Differentiation Distinguishes the Anti-pulmonary Fibrosis Efficacy of Two Danshen-Containing Chinese Herbal Medicine Prescriptions
Background: Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with limited treatment options. It also leads to progressive respiratory failure, which subsequently affects the heart functionality, a pathological heart-lung interaction increasingly noticed and defined as pulmonary-hear...
Autores principales: | Shao, Rui, Wang, Fu-jiang, Lyu, Ming, Yang, Jian, Zhang, Peng, Zhu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491955/ https://www.ncbi.nlm.nih.gov/pubmed/31105564 http://dx.doi.org/10.3389/fphar.2019.00412 |
Ejemplares similares
-
Synergism of Chinese Herbal Medicine: Illustrated by Danshen Compound
por: Su, Xuefeng, et al.
Publicado: (2016) -
Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-β/Smad2/3 Pathway
por: Jiang, Jintao, et al.
Publicado: (2020) -
Network Patterns of Herbal Combinations in Traditional Chinese Clinical Prescriptions
por: Wang, Ning, et al.
Publicado: (2021) -
MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
por: Sun, Xionghua, et al.
Publicado: (2021) -
Genome-wide DNA methylation analysis of Astragalus and Danshen on the intervention of myofibroblast activation in idiopathic pulmonary fibrosis
por: Liu, Qingyin, et al.
Publicado: (2023)